Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “COVID-19”

Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q SystemEnrolling By Invitation
NCT04369599NAUpdated Jun 30, 2026
Sponsor: Emory University
Acute Respiratory Distress Syndrome · COVID-19
United States
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in AdultsRecruiting
NCT07464314Phase 1Updated Jun 30, 2026
Sponsor: GlaxoSmithKline
Influenza, Human+COVID-19
United States
Breathing Techniques and Meditation for Health Care Workers During COVID-19 PandemicActive Not Recruiting
NCT04482647NAUpdated Jun 30, 2026
Sponsor: M.D. Anderson Cancer Center
COVID-19 Infection
United States
Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID ConditionCompleted
NCT06063031NAUpdated Jun 30, 2026
Sponsor: Instituto de Investigación Sanitaria Aragón
Post-COVID Condition
Spain
Boricua Youth Study COVID-19 Coping Intervention StudyCompleted
NCT05444881NAUpdated Jun 30, 2026
Sponsor: New York State Psychiatric Institute
Psychological Stress · Depression · Anxiety
United States
Assessment of Chilbains Occuring During Covid-19 InfectionRecruiting
NCT04344119N/AUpdated Jun 29, 2026
Sponsor: Centre Hospitalier Universitaire de Nice
Skin Manifestations · COVID · Chilblains
France
SPI-1005 Treatment in Severe COVID-19 PatientsCompleted
NCT04483973Phase 2Updated Jun 29, 2026
Sponsor: Sound Pharmaceuticals, Incorporated
Covid19 · Coronavirus · Coronavirus Infection · Corona Virus Infection
United States
Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19Completed
NCT06821087Phase 2Updated Jun 29, 2026
Sponsor: University of Texas at Austin
Long COVID
United States
Patient-Centered Practical Vaccine Talk For Busy CliniciansEnrolling By Invitation
NCT07651761NAUpdated Jun 29, 2026
Sponsor: University of Massachusetts, Worcester
Influenza · COVID-19
United States
COVID 19-Caregivers IGg SeroconversionWithdrawn
NCT04353323N/AUpdated Jun 29, 2026
Sponsor: University Hospital, Limoges
Infection, COVID-19
France
Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved PopulationCompleted
NCT04875520NAUpdated Jun 29, 2026
Sponsor: Washington University School of Medicine
Covid19
United States
A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.Completed
NCT07261085N/AUpdated Jun 29, 2026
Sponsor: Pfizer
COVID-19
United States
Atovaquone and Azithromycin Combination for Confirmed COVID-19 InfectionTerminated
NCT04339426Phase 2Updated Jun 29, 2026
Sponsor: HonorHealth Research Institute
Covid19
United States
Pulmonary Function in Patients Recovering From COVID19 Infection : a Pilot StudyActive Not Recruiting
NCT05074927NAUpdated Jun 26, 2026
Sponsor: University Hospital, Limoges
COVID-19
France
Emotional Burden of Healthcare Professionals and Covid Infection 19Completed
NCT04350099N/AUpdated Jun 26, 2026
Sponsor: University Hospital, Limoges
Emotionnal Distress; COVID-19
France
Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2)Completed
NCT05125887N/AUpdated Jun 26, 2026
Sponsor: University Hospital, Limoges
SARS-CoV2 Infection
France
COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 SectorCompleted
NCT04481529N/AUpdated Jun 26, 2026
Sponsor: University Hospital, Limoges
Infection Viral
France
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19Terminated
NCT04365101Phase 1, Phase 2Updated Jun 26, 2026
Sponsor: Celularity Incorporated
Coronavirus · Coronavirus Infection · Severe Acute Respiratory Syndrome Coronavirus 2 · Pneumonia
United States
Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in AdultsCompleted
NCT07095231Phase 1Updated Jun 26, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
COVID-19
United States
Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceActive Not Recruiting
NCT06070961N/AUpdated Jun 26, 2026
Sponsor: Fondazione Italiana Linfomi - ETS
Follicular Lymphoma
Italy
CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 PatientsCompleted
NCT04512118N/AUpdated Jun 25, 2026
Sponsor: Central Hospital, Nancy, France
Presence of COVID-19 Compatible CT Abnormalities
France
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 InfectionActive Not Recruiting
NCT06672055Phase 2Updated Jun 25, 2026
Sponsor: Vaxart
SARS-CoV2 · COVID-19
United States
Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19Completed
NCT04764721NAUpdated Jun 25, 2026
Sponsor: Central Hospital, Nancy, France
Covid-19
France
Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBOCompleted
NCT04878328NAUpdated Jun 25, 2026
Sponsor: Montefiore Medical Center
Covid19
United States
Fluvoxamine for Long COVID-19Completed
NCT05874037Phase 2, Phase 3Updated Jun 25, 2026
Sponsor: Washington University School of Medicine
Long COVID
United States

Previous page Next page